Login / Signup

The effect of proton pump inhibitors on survival outcomes in advanced hepatocellular carcinoma treated with sorafenib.

Warit RuanglertboonMichael J SorichJessica M LoganAndrew RowlandAshley M Hopkins
Published in: Journal of cancer research and clinical oncology (2020)
In a large high-quality dataset, PPI use was not observed to compromise the survival outcomes of advanced HCC patients initiated on sorafenib.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • small molecule
  • patient reported outcomes
  • protein protein